Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.

Human pathology - 1 Nov 1994

Eriksson E T, Schimmelpenning H, Aspenblad U, Zetterberg A, Auer G U

Abstract excerpt

Immunohistochemical expression of the cellular phosphoprotein p53 was investigated in archival, formalin-fixed, and paraffin-embedded surgical breast tissue specimens from 543 patients using the polyclonal antibody CM-1. Cytometric DNA assessments were performed on histopathologically or cytopathologically identified cell nuclei using image analysis. The series included five samples of normal resting breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Nucleus

Share to DNA, Neoplasm

Share to Immunohistochemistry

Share to Mutation

Share to Precancerous Conditions

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 7959668
DOI: 10.1016/0046-8177(94)90040-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.PMID 7959668Read ↗

P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.Semantic proximity Read ↗

p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.Semantic proximity Read ↗

Maintenance of p53 alterations throughout breast cancer progression.Semantic proximity Read ↗

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.Semantic proximity Read ↗

p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?Semantic proximity Read ↗

p53 protein accumulation and mutations in normal and benign breast tissue.Semantic proximity Read ↗

Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.Semantic proximity Read ↗

Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.Semantic proximity Read ↗

Detection of p53 gene mutations in fine-needle aspiration biopsied breast cancer specimens: correlations with nuclear p53 accumulations and tumor DNA aneuploidy patterns.Semantic proximity Read ↗

p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.Semantic proximity Read ↗

Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis.Semantic proximity Read ↗

Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.